The Board of Directors of Pharmaniaga Berhad (“the Company”) wishes to announce that Pharmaniaga Lifescience Sdn Bhd, a wholly-owned subsidiary of the Company has on 22 March 2021 entered into an Agreement with Government of Malaysia, represented by Ministry of Health for the supply and distribution of 200,000 doses of Covid-19 vaccine (Imported Finished Product), developed and manufactured by SINOVAC Life Sciences Co. Ltd.
Please refer to the attachment for details of the announcement.
This announcement is dated 22 March 2021.